EU Healthcare Predictions and Outlook, 2020

EU Healthcare Predictions and Outlook, 2020

Rise in Orphan Drug R&D Pipeline, AI-based Funding, and Growth in Biocontract Manufacturing to be Key Drivers of Growth

RELEASE DATE
20-Feb-2020
REGION
Europe
Research Code: MEE1-01-00-00-00
SKU: HC03266-EU-MO_24121

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03266-EU-MO_24121

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national healthcare policies and regulatory reforms that must re-invigorate future strategies. Social Determinants of Health (SDOH) will emerge as a big theme across progressive health systems as they seek to proactively engage patients and improve health outcomes that would help healthcare organizations meet quality standards.

This decade will bring significant changes and disruptions when it comes to digital-service-enabled health. Health and care delivery, as well as prevention in the 2020s, will become more consumer-centric, with AI-powered tools and virtual interactions between patients and care providers becoming the new normal in many situations. Data-driven interoperability and personalized diagnostics will accelerate the delivery of predictive-analysis-driven precision care. This will pave the way for better and efficient decision making for the patient and the provider and further drive partnerships between big tech companies that design care delivery models and healthcare organizations.

This follows the new vision for healthcare for 2020 and beyond, focusing not only on access, quality, and affordability but also on predictive, preventive, and outcome-based care models that promote social and financial inclusion. In 2020, consumer-driven models of healthcare will gain more market traction, as they stand to better bridge the gap of what consumers want and what healthcare can deliver.

Central and Eastern Europe is highly fragmented and is emerging as quite an attraction to healthcare investors. Screening services are facilitating better diagnosis of chronic conditions. The rise in disposable income and in healthcare spending is because of the presence of a rapidly aging population and their demand for better healthcare. Economic factors are also at play, with rising wages and disposable incomes freeing up personal money for healthcare-related spending. With the recent rise in minimum wages in Hungary and other recent reforms in various parts of Central and Eastern Europe, the economy in CEE and a parallel drop in unemployment rates are ideal for market participants.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Market Scope

Geographic Segmentation

Key Questions This Study Will Answer

Top Predictions for the EU Healthcare Industry, 2020

EU Healthcare Industry Forecast by Segment

EU Regional Performance Matrix

Revenue by Region

Prediction#1: By 2020, Orphan Drug R&D Pipeline will Surpass Non-orphan Drug to Account for 55% of the Total Pipeline Value

Prediction#2: Europe will Expand Biomanufacturing Capacity by ~15% to Reach a Market Share of 35% by 2020

Prediction#3: 2020 will be an Inflexion Point for Artificial Intelligence in Europe

Prediction#4: Hospital Cost Saving is Set to Increase by 25%–35% by 2020 as 15%–20% of ORs become Integrated

Prediction#5: POCT Market for Infectious Diseases will Breach the One-billion-dollar Mark in 2020

Prediction#6: Europe will Lead the Global IVF Market in 2020 and Account for 40% of Market Share

Prediction#7: The Demand for Precision Care Procedures will Fuel RASD to Reach $430 million by 2020 and Cut Complication Rates by 10%–15%

Prediction#8: Next-gen Imaging Equipment is set to Yield Annual Operational Savings of 10%–12%

Prediction#9: Medical-grade remote patient monitoring will witness a 15% growth

Prediction#10: Up to 20 New Enterprise-customer Partnerships will Redefine New Business Models

Top Pharmaceuticals and Biotechnology Growth Opportunities

Top Medical Technologies Growth Opportunities

Top Medical Imaging Equipment Growth Opportunities

Top In-Vitro Diagnostics Growth Opportunities

Top Healthcare IT Growth Opportunities

Companies to Watch Out For

Companies to Watch Out for (continued)

Healthcare IT

Medical Technologies

Medical Imaging Equipment

Pharmaceutical & Biotechnology

In-Vitro Diagnostics

UK and Europe’s Interdependencies that Support the Care Continuum

Select Indicators for Health System Assessment

Potential Disruption Across the UK Healthcare Sector

Critical Success Factors

Legal Disclaimer

List of Exhibits

List of Exhibits (continued)

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national healthcare policies and regulatory reforms that must re-invigorate future strategies. Social Determinants of Health (SDOH) will emerge as a big theme across progressive health systems as they seek to proactively engage patients and improve health outcomes that would help healthcare organizations meet quality standards. This decade will bring significant changes and disruptions when it comes to digital-service-enabled health. Health and care delivery, as well as prevention in the 2020s, will become more consumer-centric, with AI-powered tools and virtual interactions between patients and care providers becoming the new normal in many situations. Data-driven interoperability and personalized diagnostics will accelerate the delivery of predictive-analysis-driven precision care. This will pave the way for better and efficient decision making for the patient and the provider and further drive partnerships between big tech companies that design care delivery models and healthcare organizations. This follows the new vision for healthcare for 2020 and beyond, focusing not only on access, quality, and affordability but also on predictive, preventive, and outcome-based care models that promote social and financial inclusion. In 2020, consumer-driven models of healthcare will gain more market traction, as they stand to better bridge the gap of what consumers want and what healthcare can deliver. Central and Eastern Europe is highly fragmented and is emerging as quite an attraction to healthcare investors. Screening services are facilitating better diagnosis of chronic conditions. The rise in disposable income and in healthcare spending is because of the presence of a rapidly aging population and their demand for better healthcare. Economic factors are also at play, with rising wages and disposable incomes freeing up personal money for healthcare-related spending. With the recent rise in minimum wages in Hungary and other recent reforms in various parts of Central and Eastern Europe, the economy in CEE and a parallel drop in unemployment rates are ideal for market participants. Author: Bejoy Daniel
More Information
No Index No
Podcast No
Author Bejoy Daniel
Industries Healthcare
WIP Number MEE1-01-00-00-00
Is Prebook No
GPS Codes 9575-B1,9600-B1,9612-B1,9570-B1,9571-B1,9573-B1,9A48-B1,9A4B-B1,9611-B1,9614-B1,9627-B1